Clincosm LogoSign in Get a demo

influenza, human

Showing 1 - 25 of 175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

Not yet recruiting
  • Influenza, Human
  • ARCT-2138
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic
Nov 8, 2023

Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)

Not yet recruiting
  • Influenza, Human
  • aQIV
  • QIV
  • Batumi, Georgia
  • +16 more
Oct 11, 2023

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)

Not yet recruiting
  • Influenza, Human
  • Investigational aQIVc
  • +2 more
  • (no location specified)
Aug 28, 2023

SARS CoV 2 Infection, Influenza, Human Trial in Spain (BIMERVAX, SIIV)

Not yet recruiting
  • SARS CoV 2 Infection
  • Influenza, Human
  • BIMERVAX
  • SIIV
  • Santiago De Compostela, A Coruña, Spain
  • +7 more
Aug 8, 2023

Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)

Not yet recruiting
  • Influenza, Human
  • FLU Q-PAN H5N8 Formulation 1
  • +3 more
  • (no location specified)
Jul 27, 2023

Influenza, Human Trial in Shanghai (ZX-7101A, Placebo)

Not yet recruiting
  • Influenza, Human
  • Shanghai, Shanghai, China
    Huashan Hospital affiliated to Fudan University
Jul 20, 2023

Influenza, Human Trial in Gentofte, Copenhagen, Hillerød (Vaxigripetra, Flumist)

Not yet recruiting
  • Influenza, Human
  • Vaxigripetra
  • Flumist
  • Gentofte, Copenhagen, Denmark
  • +5 more
Jul 4, 2023

Influenza, Human, Infections, Respiratory Tract Infections Trial in Philippines, United States (Low dose A/H2N3c + standard dose

Not yet recruiting
  • Influenza, Human
  • +4 more
  • Low dose A/H2N3c + standard dose MF59
  • +5 more
  • Rockville, Maryland
  • +7 more
May 26, 2023

Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on

Not yet recruiting
  • Influenza, Human
  • +4 more
  • aH5N8c on Day 1
  • +4 more
  • Cullman, Alabama
  • +8 more
May 15, 2023

Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

Completed
  • Influenza
  • +4 more
  • Influenza vaccine [inactivated]
  • Kol'tsovo, Novosibirsk Region, Russian Federation
  • +4 more
May 11, 2023

Patients Given Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine

Recruiting
  • Influenza, Human
  • COVID-19
  • Comirnaty
  • Quadrivalent Influenza Vaccine
  • New York, New York
    Pfizer
May 11, 2023

Zoonotic Influenza Surveillance in Belgium

Not yet recruiting
  • Influenza, Human
  • respiratory specimen
  • serum
  • (no location specified)
Apr 12, 2023

Influenza, Human Trial (Flu mRNA, Control 1, Control 2)

Not yet recruiting
  • Influenza, Human
  • Flu mRNA
  • +2 more
  • (no location specified)
Apr 21, 2023

Influenza, Human Trial (Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion,

Not yet recruiting
  • Influenza, Human
  • Quadrivalent Influenza Vaccine (split virion, inactivated)
  • +2 more
  • (no location specified)
Mar 9, 2023

Influenza, Human Trial in Leiden (POLB 001, Placebo)

Completed
  • Influenza, Human
  • POLB 001
  • Placebo
  • Leiden, Netherlands
    Centre for Human Drug Research
Mar 13, 2023

Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

Recruiting
  • Influenza
  • +3 more
  • Influenza vaccine [inactivated]
  • Ekaterinburg, Russian Federation
  • +6 more
Feb 13, 2023

Influenza, Human Trial (ZX-7101A 80mg)

Not yet recruiting
  • Influenza, Human
  • ZX-7101A 80mg
  • (no location specified)
Feb 6, 2023

Influenza, Human Trial in Shanghai (ZX-7101A 80mg)

Recruiting
  • Influenza, Human
  • ZX-7101A 80mg
  • Shanghai, China
    Shuguang Hospital, Shanghai University of Traditional Chinese Me
Feb 2, 2023

Influenza, Influenza, Human Trial in Bangkok (Drug: Oseltamivir, Drug: Favipiravir, Drug: Zanamivir)

Not yet recruiting
  • Influenza
  • Influenza, Human
  • Drug: Oseltamivir
  • +6 more
  • Bangkok, Thailand
    Faculty of Tropical Medicine, Mahidol University
Jan 30, 2023

Influenza, Human Trial in Shanghai (ZX-7101A)

Recruiting
  • Influenza, Human
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Jan 25, 2023

Influenza, Human Trial (Fluarix Tetra Vaccine)

Not yet recruiting
  • Influenza, Human
  • Fluarix Tetra Vaccine
  • (no location specified)
Jan 20, 2023

Influenza, Human Trial in United States (PF-07852352 Influenza saRNA 1, PF-07836391 Influenza saRNA, PF-07836394 Influenza

Recruiting
  • Influenza, Human
  • PF-07852352 Influenza saRNA 1
  • +10 more
  • Phoenix, Arizona
  • +23 more
Jan 17, 2023

Influenza, Human Trial in Worldwide (QIVc, Comparator)

Active, not recruiting
  • Influenza, Human
  • QIVc
  • Comparator
  • Dobrich, Bulgaria
  • +54 more
Jan 17, 2023

Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)

Active, not recruiting
  • Influenza, Human
  • GSK4382276A Dose level 1
  • +4 more
  • Edegem, Belgium
  • +6 more
Jan 9, 2023